{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:55:40Z","timestamp":1788357340753,"version":"build-2803163510"},"reference-count":99,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ersjournals.com"],"crossmark-restriction":true},"short-container-title":["Breathe"],"accepted":{"date-parts":[[2021,5,11]]},"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>Airway diseases were initially described by nonspecific patterns of symptoms, for example \u201cdry and wheezy\u201d and \u201cwet and crackly\u201d. The model airway disease is cystic fibrosis, which has progressed from nonspecific reactive treatments such as antibiotics for airway infection to molecular sub-endotype, proactive therapies with an unequivocal evidence base, early diagnosis, and biomarkers of treatment efficacy. Unfortunately, other airway diseases lag behind, not least because nonspecific umbrella labels such as \u201casthma\u201d are considered to be diagnoses not mere descriptions.<\/jats:p><jats:p>Pending the delineation of molecular sub-endotypes in other airway disease the concept of treatable traits, and consideration of airway disease in a wider context is preferable. A treatable trait is a characteristic amenable to therapy, with measurable benefits of treatment. This approach determines what pathology is actually present and treatable, rather than using umbrella labels. We determine if airway inflammation is present, and whether there is airway eosinophilia which will likely respond to inhaled corticosteroids; whether there is variable airflow obstruction due to bronchoconstriction which will respond to \u03b2<jats:sub>2<\/jats:sub>-agonists; and whether there is unsuspected underlying airway infection which should be treated with antibiotics unless there is an underlying endotype which can be addressed, as for example an immunodeficiency. The context of airway disease should also be extrapulmonary comorbidities, social and environmental factors, and a developmental perspective, particularly this last aspect if preventive strategies are being contemplated. This approach allows targeted treatment for maximal patient benefit, as well as preventing the discarding of therapies which are useful for appropriate subgroups of patients. Failure to appreciate this almost led to the discarding of valuable treatments such as prednisolone.<\/jats:p><jats:sec><jats:title>Educational aims<\/jats:title><jats:list list-type=\"bullet\"><jats:list-item><jats:p>To use cystic fibrosis as a paradigm to show the benefits of the journey from nonspecific umbrella terms to specific endotypes and sub-endotypes, as a road map for other airway diseases to follow.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Demonstrate that nonspecific labels to describe airway disease can and should be abandoned in favour of treatable traits to ensure diagnostic and therapeutic precision.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Begin to learn to see airway disease in the context of extrapulmonary comorbidities, and social and environmental factors, as well as with a developmental perspective.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:sec>","DOI":"10.1183\/20734735.0053-2021","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:30:33Z","timestamp":1630485033000},"page":"210053","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease"],"prefix":"10.1183","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6756-9822","authenticated-orcid":false,"given":"Andrew","family":"Bush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"2024101703580439000_17.3.210053.1","first-page":"124","article-title":"Onward and upward: beyond personalized medicine to proactive medicine","volume":"33","author":"Bush","year":"2020","journal-title":"Paediat Aller Imm Pul"},{"key":"2024101703580439000_17.3.210053.2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1938.01980140114013"},{"key":"2024101703580439000_17.3.210053.3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1542\/peds.12.5.549","article-title":"Abnormal electrolyte composition of sweat in cystic fibtrosis and relationship to disease","volume":"12","author":"Di Sant'Agnese","year":"1953","journal-title":"Pediatrics"},{"key":"2024101703580439000_17.3.210053.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.2772657"},{"key":"2024101703580439000_17.3.210053.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.2570460"},{"key":"2024101703580439000_17.3.210053.6","doi-asserted-by":"publisher","DOI":"10.1126\/science.2475911"},{"key":"2024101703580439000_17.3.210053.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207588"},{"key":"2024101703580439000_17.3.210053.8","unstructured":"Cystic Fibrosis Foundation , Johns Hopkins Medicine . CFTR2 website. https:\/\/cftr2.org\/"},{"key":"2024101703580439000_17.3.210053.9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"De Boeck","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024101703580439000_17.3.210053.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"2024101703580439000_17.3.210053.11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s41030-020-00129-2","article-title":"Long-term ivacaftor in people aged 6 years and older with cystic fibrosis with ivacaftor-responsive mutations","volume":"6","author":"Pilewski","year":"2020","journal-title":"Pulm Ther"},{"key":"2024101703580439000_17.3.210053.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807119"},{"key":"2024101703580439000_17.3.210053.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024101703580439000_17.3.210053.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200407-895OC"},{"key":"2024101703580439000_17.3.210053.15","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.068262"},{"key":"2024101703580439000_17.3.210053.16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S2213-2600(13)70182-6","article-title":"Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial","volume":"1","author":"Davies","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2024101703580439000_17.3.210053.17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcf.2019.03.009","article-title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2\u20135\u2005years (KLIMB)","volume":"18","author":"Rosenfeld","year":"2019","journal-title":"J Cyst Fibros"},{"key":"2024101703580439000_17.3.210053.18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1164\/rccm.201808-1436LE","article-title":"Might brushed nasal cells be a surrogate for CFTR modulator clinical response?","volume":"199","author":"Pranke","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101703580439000_17.3.210053.19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02426-2019"},{"key":"2024101703580439000_17.3.210053.20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/rccm.201906-1204LE","article-title":"Successful treatment of interstitial lung disease in STAT3 gain-of-function using JAK inhibitors","volume":"202","author":"Silva-Carmona","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101703580439000_17.3.210053.21","doi-asserted-by":"publisher","DOI":"10.1136\/thx.36.4.245"},{"key":"2024101703580439000_17.3.210053.22","first-page":"1185","article-title":"A clinical survey of 1074 patients with asthma followed for two years","volume":"12","author":"Rackemann","year":"1927","journal-title":"J Lab Clin Med"},{"key":"2024101703580439000_17.3.210053.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(58)91385-0"},{"key":"2024101703580439000_17.3.210053.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03496-6"},{"key":"2024101703580439000_17.3.210053.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805435"},{"key":"2024101703580439000_17.3.210053.26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808991"},{"key":"2024101703580439000_17.3.210053.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2024101703580439000_17.3.210053.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6438.185-b"},{"key":"2024101703580439000_17.3.210053.29","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-314180"},{"key":"2024101703580439000_17.3.210053.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30879-6"},{"key":"2024101703580439000_17.3.210053.31","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01359-2015"},{"key":"2024101703580439000_17.3.210053.32","doi-asserted-by":"crossref","unstructured":"Bush A . Impact of early life exposures on respiratory disease. Pediatr Respir Rev 2021; in press [https:\/\/doi.org\/10.1016\/j.prrv.2021.05.006].","DOI":"10.1016\/j.prrv.2021.05.006"},{"key":"2024101703580439000_17.3.210053.33","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00104809"},{"key":"2024101703580439000_17.3.210053.34","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.152140"},{"key":"2024101703580439000_17.3.210053.35","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S196200"},{"key":"2024101703580439000_17.3.210053.36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02221-2017"},{"key":"2024101703580439000_17.3.210053.37","doi-asserted-by":"publisher","DOI":"10.1136\/adc.82.4.327"},{"key":"2024101703580439000_17.3.210053.38","doi-asserted-by":"publisher","DOI":"10.1136\/adc.84.1.31"},{"key":"2024101703580439000_17.3.210053.39","doi-asserted-by":"publisher","DOI":"10.1136\/adc.84.1.35"},{"key":"2024101703580439000_17.3.210053.40","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00002108"},{"key":"2024101703580439000_17.3.210053.41","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00199913"},{"key":"2024101703580439000_17.3.210053.42","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-2867"},{"key":"2024101703580439000_17.3.210053.43","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jaci.2018.12.985","article-title":"Lower airway microbiota associates with inflammatory phenotype in severe preschool wheeze","volume":"143","author":"Robinson","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2024101703580439000_17.3.210053.44","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2016.09.028","article-title":"Individualized therapy for persistent asthma in young children","volume":"138","author":"Fitzpatrick","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2024101703580439000_17.3.210053.45","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23366"},{"key":"2024101703580439000_17.3.210053.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051378"},{"key":"2024101703580439000_17.3.210053.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69285-4"},{"key":"2024101703580439000_17.3.210053.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054692"},{"key":"2024101703580439000_17.3.210053.49","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200410-1404OC"},{"key":"2024101703580439000_17.3.210053.50","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200702-212OC"},{"key":"2024101703580439000_17.3.210053.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508749"},{"key":"2024101703580439000_17.3.210053.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052632"},{"key":"2024101703580439000_17.3.210053.53","doi-asserted-by":"crossref","unstructured":"Nieto A , Mazon A , Uixera S , et al. Bacterial mucosal immunotherapy with MV130 prevents recurrent wheezing in children: a randomized, double-blind, placebo controlled trial. Am J Respir Crit Care Med 2021; in press [https:\/\/doi.org\/10.1164\/rccm.202003-0520OC].","DOI":"10.1164\/rccm.202003-0520OC"},{"key":"2024101703580439000_17.3.210053.54","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X683965"},{"key":"2024101703580439000_17.3.210053.55","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23541"},{"key":"2024101703580439000_17.3.210053.56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19627"},{"key":"2024101703580439000_17.3.210053.57","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.7.643"},{"key":"2024101703580439000_17.3.210053.58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814917"},{"key":"2024101703580439000_17.3.210053.59","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202698"},{"key":"2024101703580439000_17.3.210053.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.10.011"},{"key":"2024101703580439000_17.3.210053.61","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaci.2016.09.022","article-title":"Intra-epithelial neutrophils in paediatric severe asthma are associated with better lung function","volume":"139","author":"Andersson","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2024101703580439000_17.3.210053.62","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/JAA.S129159","article-title":"Managing the paediatric patient with refractory asthma: a multidisciplinary approach","volume":"10","author":"Cook","year":"2017","journal-title":"J Asthma Allergy"},{"key":"2024101703580439000_17.3.210053.63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001278"},{"key":"2024101703580439000_17.3.210053.64","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204815"},{"key":"2024101703580439000_17.3.210053.65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","article-title":"Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life","volume":"6","author":"Bui","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2024101703580439000_17.3.210053.66","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201110-1922OC"},{"key":"2024101703580439000_17.3.210053.67","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1164\/rccm.201802-0274OC","article-title":"A longitudinal study","volume":"198","author":"Mahmoud","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101703580439000_17.3.210053.68","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2213-2600(17)30434-4","article-title":"Lung function in early adulthood and health in later life: a transgenerational cohort analysis","volume":"5","author":"Agust\u00ed","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024101703580439000_17.3.210053.69","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61447-6"},{"key":"2024101703580439000_17.3.210053.70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131959"},{"key":"2024101703580439000_17.3.210053.71","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206740"},{"key":"2024101703580439000_17.3.210053.72","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207228"},{"key":"2024101703580439000_17.3.210053.73","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207021"},{"key":"2024101703580439000_17.3.210053.74","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708208"},{"key":"2024101703580439000_17.3.210053.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03820-2020"},{"key":"2024101703580439000_17.3.210053.76","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00588-2019"},{"key":"2024101703580439000_17.3.210053.77","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.137414"},{"key":"2024101703580439000_17.3.210053.78","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31281-3"},{"key":"2024101703580439000_17.3.210053.79","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00194-2020"},{"key":"2024101703580439000_17.3.210053.80","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01836-2020"},{"key":"2024101703580439000_17.3.210053.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.01.048"},{"key":"2024101703580439000_17.3.210053.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.01.059"},{"key":"2024101703580439000_17.3.210053.83","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.jaci.2017.08.020","article-title":"T H 1 signatures are present in the lower airways of children with severe asthma, regardless of allergic status","volume":"141","author":"Wisniewski","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2024101703580439000_17.3.210053.84","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201064"},{"key":"2024101703580439000_17.3.210053.85","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2156LE"},{"key":"2024101703580439000_17.3.210053.86","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02135-2016"},{"key":"2024101703580439000_17.3.210053.87","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1470OC"},{"key":"2024101703580439000_17.3.210053.88","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S2213-2600(16)30048-0","article-title":"Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts","volume":"4","author":"Peters","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024101703580439000_17.3.210053.89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201605-1039OC","article-title":"Obesity and airway dysanapsis in children with and without asthma","volume":"195","author":"Forno","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024101703580439000_17.3.210053.90","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2011-201506"},{"key":"2024101703580439000_17.3.210053.91","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3389\/fped.2017.00264","article-title":"Persistent bacterial bronchitis: time to venture beyond the umbrella","volume":"5","author":"Bush","year":"2017","journal-title":"Front Pediatr"},{"key":"2024101703580439000_17.3.210053.92","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21317"},{"key":"2024101703580439000_17.3.210053.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2013.09.057"},{"key":"2024101703580439000_17.3.210053.94","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200912-1806OC"},{"key":"2024101703580439000_17.3.210053.95","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2012-302115"},{"key":"2024101703580439000_17.3.210053.96","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0066-2015"},{"key":"2024101703580439000_17.3.210053.97","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.115188"},{"key":"2024101703580439000_17.3.210053.98","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-204464"},{"key":"2024101703580439000_17.3.210053.99","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00382-2019"}],"container-title":["Breathe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/20734735.0053-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:41:30Z","timestamp":1729165290000},"score":1,"resource":{"primary":{"URL":"http:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/20734735.0053-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":99,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,9,1]]},"published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1183\/20734735.0053-2021"],"URL":"https:\/\/doi.org\/10.1183\/20734735.0053-2021","relation":{},"ISSN":["1810-6838","2073-4735"],"issn-type":[{"value":"1810-6838","type":"print"},{"value":"2073-4735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}